Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Srinand Sreevatsan is active.

Publication


Featured researches published by Srinand Sreevatsan.


Journal of Clinical Investigation | 1997

Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains.

Slawomir Lukomski; Srinand Sreevatsan; Cornelia Amberg; Werner Reichardt; Markus Woischnik; Andreas Podbielski; James M. Musser

Cysteine proteases have been implicated as important virulence factors in a wide range of prokaryotic and eukaryotic pathogens, but little direct evidence has been presented to support this notion. Virtually all strains of the human bacterial pathogen Streptococcus pyogenes express a highly conserved extracellular cysteine protease known as streptococcal pyrogenic exotoxin B (SpeB). Two sets of isogenic strains deficient in SpeB cysteine protease activity were constructed by integrational mutagenesis using nonreplicating recombinant plasmids containing a truncated segment of the speB gene. Immunoblot analyses and enzyme assays confirmed that the mutant derivatives were deficient in expression of enzymatically active SpeB cysteine protease. To test the hypothesis that the cysteine protease participates in host mortality, we assessed the ability of serotype M3 and M49 wild-type strains and isogenic protease-negative mutants to cause death in outbred mice after intraperitoneal inoculation. Compared to wild-type parental organisms, the serotype M3 speB mutant lost virtually all ability to cause mouse death (P < 0.00001), and similarly, the virulence of the M49 mutant was detrimentally altered (P < 0.005). The data unambiguously demonstrate that the streptococcal enzyme is a virulence factor, and thereby provide additional evidence that microbial cysteine proteases are critical in host-pathogen interactions.


Proceedings of the National Academy of Sciences of the United States of America | 1997

Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination

Srinand Sreevatsan; Xi Pan; Kathryn E. Stockbauer; Nancy D. Connell; Barry N. Kreiswirth; Thomas S. Whittam; James M. Musser


Nature Medicine | 1997

The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol

Amalio Telenti; Wolfgang Philipp; Srinand Sreevatsan; Claudia Bernasconi; Kathryn E. Stockbauer; Brigitte Wieles; James M. Musser; William R. Jacobs


Antimicrobial Agents and Chemotherapy | 1997

Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Srinand Sreevatsan; Kathryn E. Stockbauer; Xi Pan; Barry N. Kreiswirth; Soraya L. Moghazeh; William R. Jacobs; Amalio Telenti; James M. Musser


Antimicrobial Agents and Chemotherapy | 1997

Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms.

Srinand Sreevatsan; Xi Pan; Ying Zhang; Barry N. Kreiswirth; James M. Musser


Antimicrobial Agents and Chemotherapy | 1996

Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities.

Srinand Sreevatsan; Xi Pan; Kathryn E. Stockbauer; Diana L. Williams; Barry N. Kreiswirth; James M. Musser


Antimicrobial Agents and Chemotherapy | 1997

Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities.

Srinand Sreevatsan; Xi Pan; Y. Zhang; Vojo Deretic; James M. Musser


The Journal of Infectious Diseases | 1996

Fluoroquinolone Resistance Associated with Specific Gyrase Mutations in Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis

Chen Xu; Barry N. Kreiswirth; Srinand Sreevatsan; James M. Musser; Karl Drlica


Journal of Biological Chemistry | 1997

MMAS-1, the Branch Point Between cis- and trans-Cyclopropane-containing Oxygenated Mycolates in Mycobacterium tuberculosis

Ying Yuan; Deborah C. Crane; James M. Musser; Srinand Sreevatsan; Clifton E. Barry


The Journal of Infectious Diseases | 1997

Erratum: Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis (Journal of Infectious Diseases (December, 1996) 174 (1127- 1130))

Chen Xu; Barry N. Kreiswirth; Srinand Sreevatsan; James M. Musser; Karl Drlica

Collaboration


Dive into the Srinand Sreevatsan's collaboration.

Top Co-Authors

Avatar

James M. Musser

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xi Pan

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chen Xu

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Diana L. Williams

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar

Karl Drlica

Rutgers Biomedical and Health Sciences

View shared research outputs
Top Co-Authors

Avatar

William R. Jacobs

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Amalio Telenti

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Clifton E. Barry

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge